Home / Tag Archives: FDA (page 2)

Tag Archives: FDA

Potomac Officers Club Rounds Out Speakers For 2017 Healthcare Forum

TYSONS CORNER, VA., March 20, 2017 — The Potomac Officers Club — a division of Executive Mosaic — rounded out the speakers list for their 2017 Healthcare Forum to be held on March 23rd. The Healthcare Forum will present leaders in both the public and private sector discussing digital healthcare, interoperability and …

Read More »

Potomac Officers Club Presents Speakers For 2017 Healthcare Forum

TYSONS CORNER, VA., March 14, 2017 — The Potomac Officers Club — a division of Executive Mosaic — released the speakers list for their 2017 Healthcare Forum. The Healthcare Forum will present leaders in both the public and private sector discussing digital healthcare, interoperability and cybersecurity. The new era of medicine incorporates …

Read More »

CSRA’s DynPort Vaccine Company Gets Orphan Drug Designation on Plague Vaccine

TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and Drug Administration on a plague vaccine it is developing as a potential pre-exposure prophlaxis treatment against Yersinia pestis infection, ExecutiveBiz reported Thursday. The company said Wednesday the designation enables DynPort Vaccine Company to …

Read More »

SRI International Lands 2 BARDA Nonclinical Research Service Contracts Worth $90M

SRI International has received a pair of contracts worth a combined $90 million to help  the Biomedical Advanced Research and Development Authority assess compounds that have potential to treat people exposed to chemical, biological, radiological or nuclear weapons. The company said Wednesday that both contracts have a base period of five years and cover …

Read More »

Weekly Roundup February 27 – March 3 2017: The Potomac Officers Club Hosts A Successful 4th Annual Intel Summit & More

Weekly Roundup February 27 – March 3 2017 Click here to see Real-Time GovCon Sector Quotes A Note From Our President & Founder Jim Garrettson The Potomac Officers Club (POC) hosted its 4th Annual Intel Summit this past Wednesday morning at the Ritz-Carlton Tysons Corner featuring a keynote address from Robert …

Read More »

IBM, FDA to Study Blockchain Technology Application for Health Data

TYSONS CORNER, VA, Jan. 13, 2017 — IBM‘s (NYSE: IBM) Watson Health unit has entered into a research initiative with the U.S. Food and Drug Administration in an effort to explore blockchain technology application for health data, ExecutiveBiz reported Thursday. The company said Wednesday it will work with the agency to study oncology-related …

Read More »

SRI Lands $150M NIH Contract to Help Develop Candidate HIV Prevention Products

SRI International has secured a seven-year, $150 million contract from the National Institutes of Health to provide development services for candidate HIV prevention products from investigator-initiated studies or from partnerships with other companies and organizations. SRI said Tuesday its biosciences division will manufacture and characterize drug products to support the development of …

Read More »

Health IT Vet Brooke Patterson Named ARDX Govt Services SVP

Brooke Patterson, formerly vice president and deputy general manager of FEI Systems, has been appointed senior VP for government services at Norfolk, Virginia-based healthcare management and information technology consulting firm ARDX. ARDX said Tuesday that Patterson will oversee the company’s efforts to expand and implement healthcare technology offerings for federal, state and local government …

Read More »

Engility Highlights 3Q Contract Bookings in ‘Best-Value’ Strategy Shift Versus LPTA

Engility Corp. (NYSE: EGL) described to investors Thursday three third quarter contract wins and the loss of another as examples of its shift toward pursuits of larger “best-value” programs versus lowest-price, technically-acceptable work. A slide in the company’s third quarter earnings call presentation highlighted its potential five-year, $369 million contract announced in October for engineering and technical services …

Read More »

Engility Lands $112M FDA Computational Science, Bioinformatics Services IDIQ; Lynn Dugle Comments

The Food and Drug Administration has awarded Engility (NYSE: EGL) a potential five-year, $112 million indefinite-delivery/indefinite-quantity contract to provide computational science and bioinformatics services for the FDA’s gene-based drug discovery and development programs. Engility said Thursday it will help the FDA operate, secure and maintain scientific computing environments and systems designed …

Read More »